268. Subcallosal Cingulate Deep Brain Stimulation for Depression: Long-Term Safety and Effectiveness Outcomes From a Pooled Analysis of 172 Patients
Lyndahl Himes(Abbott (United Kingdom)), Patricio Riva‐Posse(Emory University), Mustafa M. Husain(The University of Texas Southwestern Medical Center), Martijn Figee(Circuit Therapeutics (United States)), Alon Y. Mogilner(NYU Langone Health), Helen S. Mayberg(Icahn School of Medicine at Mount Sinai), Konstantin V. Slavin(University of Illinois Chicago), Julie G. Pilitsis(University of Arizona), Devyani Nanduri(Abbott Fund), Sidney H. Kennedy(University of Toronto), Paul E. Holtzheimer(Emory University), Clement Hamani(University Health Network), Yagna Pathak(Columbia University Irving Medical Center), Andrés M. Lozano(University of Toronto), Robert A. Gross(University of Pennsylvania), Binith Cheeran(Abbott (United States)), Joseph S. Neimat, Peter Giacobbe(University of Toronto), Nader Pouratian(University of California, Los Angeles), Adele Barnard(Nevro (United States)), Brian H. Kopell(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Deep Brain Stimulation for Treatment-Resistant Depression
|Neuron|2005|4.1k
Toward discovery science of human brain function
|Proceedings of the National Academy of Sciences|2010|3.1k
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
|Nature Medicine|2016|2.2k